LCN2 and cancer: Using computational and immunohistochemistry examinations, LCN2 expression has been shown to be a suppressor of invasion and angiogenesis in six cancer types, such as bladder, colorectal, liver, lung, ovarian and pancreatic when compared to matched primary lesions [36].